The speakers discuss GLP-1 drugs like Ozempic for weight loss and diabetes management. One speaker acknowledges the potential benefits for morbidly obese individuals with existing health conditions, but also mentions the potential side-effects and the possibility for compounding the GLP-1 drugs at lower doses, which may provide a good cost-benefit analysis.
12/31/2024
"Mentioned as a treatment used to get skinny for people."
3/7/2025
"The speaker mentions the proliferation of GLP-1 prescriptions via telemedicine companies for weight loss. They also sell the pharmaceutical as a company."
3/27/2025
"Ozempic is mentioned in reference to Lizzo's weight loss, it does not make you in shape it makes you skinny. The fitness signal of people in shape that did the work, are being derated by it."
3/31/2025
"The speaker discusses the potential benefits of GLP-1 drugs for weight loss, addiction breaking, cancer prevention, and anti-aging, emphasizing their potential to revolutionize healthcare. He also mentions how society could make it broadly and cheaply available as opposed to just milk it for obesity. Bernie sanders is used in comparison of the idea of making them free."
5/22/2025
"The podcaster talks about people who are in shape may be threatened by Ompic users who they deem get to an in shape look quicker and easier."
4/3/2025
"Semaglutide and similar GLP-1 drugs are mentioned in the context of prescription medications for diabetes that also aid in weight loss by influencing the GLP-1 pathway. While impactful, they are prescription-only."
4/14/2025
"The speakers discuss GLP-1 agonist medications like Ozempic as a pharmaceutical intervention for weight loss, discussing both potential benefits and risks/side effects."
4/21/2025
"Ozempic and Wegovy, which are GLP-1 agonists, are mentioned in the context of potential off-label use for treating addiction by reducing cravings."
4/30/2025
"The speakers mention Ozempic as a quick fix for weight loss, contrasting it with the effort required for long-term lifestyle changes."
"The speaker mentions being called "anti-science" on CNN for suggesting caution around drugs like Ozempic. They also discuss the cost-benefit analysis of GLP-1 drugs."